Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Exner

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Physical Review Letters|June 23, 2025
High Precision Spectroscopy of Trilobite Rydberg MoleculesMarkus Exner, Rohan Srikumar, Richard Blättner, et al.
The New England Journal of Medicine|July 16, 2004
Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomasBerthold Streubel, Andreas Chott, Daniela Huber, et al.
Thrombosis and Haemostasis|December 24, 2003
E-Selectin and restenosis after femoropopliteal angioplasty: prognostic impact of the Ser128Arg genotype and plasma levelsWolfgang Mlekusch, Markus Exner, Martin Schillinger, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|June 4, 2004
Excessive carotid in-stent neointimal formation predicts late cardiovascular eventsMartin Schillinger, Markus Exner, Schila Sabeti, et al.
Pediatric Transplantation|May 23, 2006
C4d in pediatric renal allograft biopsies: a marker for negative outcome in steroid-resistant rejectionRegina Vargha, Thomas Mueller, Klaus Arbeiter, et al.
Thrombosis and Haemostasis|September 30, 2003
Plasminogen activator inhibitor-1 and outcome after femoropopliteal angioplasty: analysis of genotype and plasma levelsWolfgang Mlekusch, Martin Schillinger, Markus Exner, et al.
Human Immunology|June 7, 2005
[C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodiesMarkus Wahrmann, Markus Exner, Bettina Haidbauer, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 26, 2008
Xylosyltransferase I variants and their impact on abdominal aortic aneurysmsChristian Götting, Christian Prante, Martin Schillinger, et al.
Journal of Hypertension|September 22, 2007
The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cellsHilde Laggner, Marcela Hermann, Harald Esterbauer, et al.
Free Radical Research|March 17, 2007
The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?Hilde Laggner, Sabine Schreier, Marcela Hermann, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Physical Review Letters|June 23, 2025
High Precision Spectroscopy of Trilobite Rydberg MoleculesMarkus Exner, Rohan Srikumar, Richard Blättner, et al.
The New England Journal of Medicine|July 16, 2004
Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomasBerthold Streubel, Andreas Chott, Daniela Huber, et al.
Thrombosis and Haemostasis|December 24, 2003
E-Selectin and restenosis after femoropopliteal angioplasty: prognostic impact of the Ser128Arg genotype and plasma levelsWolfgang Mlekusch, Markus Exner, Martin Schillinger, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|June 4, 2004
Excessive carotid in-stent neointimal formation predicts late cardiovascular eventsMartin Schillinger, Markus Exner, Schila Sabeti, et al.
Pediatric Transplantation|May 23, 2006
C4d in pediatric renal allograft biopsies: a marker for negative outcome in steroid-resistant rejectionRegina Vargha, Thomas Mueller, Klaus Arbeiter, et al.
Thrombosis and Haemostasis|September 30, 2003
Plasminogen activator inhibitor-1 and outcome after femoropopliteal angioplasty: analysis of genotype and plasma levelsWolfgang Mlekusch, Martin Schillinger, Markus Exner, et al.
Human Immunology|June 7, 2005
[C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodiesMarkus Wahrmann, Markus Exner, Bettina Haidbauer, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 26, 2008
Xylosyltransferase I variants and their impact on abdominal aortic aneurysmsChristian Götting, Christian Prante, Martin Schillinger, et al.
Journal of Hypertension|September 22, 2007
The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cellsHilde Laggner, Marcela Hermann, Harald Esterbauer, et al.
Free Radical Research|March 17, 2007
The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?Hilde Laggner, Sabine Schreier, Marcela Hermann, et al.
Pageof 11